Kathy Y. Yi
2019
Compensation breakdown
| Option Awards | $692,157 |
|---|---|
| Salary | $175,428 |
| Stock Awards | $173,828 |
| Other | $28,174 |
| Total | $1,069,587 |
Yi received $692.2K in option awards, accounting for 65% of the total pay in 2019.
Yi also received $175.4K in salary, $173.8K in stock awards and $28.2K in other compensation.
Rankings
In 2019, Kathy Y. Yi's compensation ranked 8,984th out of 13,971 executives tracked by ExecPay. In other words, Yi earned more than 35.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,984 out of 13,971 | 36th |
Division Manufacturing | 3,595 out of 5,692 | 37th |
Major group Chemicals And Allied Products | 1,355 out of 2,189 | 38th |
Industry group Drugs | 1,155 out of 1,875 | 38th |
Industry Biological Products, Except Diagnostic Substances | 262 out of 389 | 33rd |
Pay ratio
| Kathy Y. Yi's Pay | $1,069,587 |
|---|---|
| Median Employee's Pay | $159,900 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Kathy Y. Yi was $1,069,587.
The annual total compensation of the median employee at Sangamo Biosciences was $159,900.
The ratio of Kathy Y. Yi's pay to the pay of median employee was therefore 7 to one.
Yi's colleagues
We found six more compensation records of executives who worked with Kathy Y. Yi at Sangamo Biosciences in 2019.
2019
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2019
Sung Lee
Sangamo Biosciences
Chief Financial Officer
2019
Adrian Woolfson
Sangamo Biosciences
Executive Vice President, Research and Development
2019
Gary Loeb
Sangamo Biosciences
General Counsel
2019
Stéphane Boissel
Sangamo Biosciences
Chief Financial Officer
2019
R Ramelmeier
Sangamo Biosciences